Enanta Pharmaceuticals shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Enanta Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Enanta Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enanta Pharmaceuticals by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $724k | 61k | 11.97 |
| 2025-06-30 | $419k | 56k | 7.56 |
| 2025-03-31 | $294k | 53k | 5.52 |
| 2024-12-31 | $328k | 57k | 5.75 |
| 2024-09-30 | $602k | 58k | 10.36 |
| 2024-06-30 | $958k | 74k | 12.97 |
| 2024-03-31 | $1.1M | 65k | 17.46 |
| 2023-12-31 | $683k | 73k | 9.41 |
| 2023-09-30 | $1.2M | 108k | 11.17 |
| 2023-06-30 | $3.5M | 166k | 21.40 |
| 2023-03-31 | $6.8M | 168k | 40.44 |
| 2022-12-31 | $7.8M | 168k | 46.52 |
| 2022-09-30 | $9.0M | 174k | 51.94 |
| 2022-06-30 | $7.9M | 168k | 47.27 |
| 2022-03-31 | $13M | 183k | 71.18 |
| 2021-12-31 | $15M | 196k | 74.29 |
| 2021-09-30 | $10M | 183k | 56.81 |
| 2021-06-30 | $7.8M | 176k | 44.01 |
| 2021-03-31 | $9.6M | 194k | 49.31 |
| 2020-12-31 | $8.1M | 193k | 42.10 |
| 2020-09-30 | $9.0M | 197k | 45.78 |
| 2020-06-30 | $9.6M | 191k | 50.24 |
| 2020-03-31 | $9.5M | 185k | 51.43 |
| 2019-12-31 | $12M | 189k | 61.79 |
| 2019-09-30 | $12M | 196k | 60.08 |
| 2019-06-30 | $17M | 196k | 84.38 |
| 2019-03-31 | $25M | 256k | 95.52 |
| 2018-12-31 | $18M | 255k | 70.83 |
| 2018-09-30 | $22M | 256k | 85.46 |
| 2018-06-30 | $29M | 247k | 115.90 |
| 2018-03-31 | $20M | 249k | 80.91 |
| 2017-12-31 | $10M | 174k | 58.68 |
| 2017-06-30 | $6.9M | 192k | 35.98 |
| 2017-03-31 | $6.1M | 199k | 30.80 |
| 2016-12-31 | $6.5M | 194k | 33.49 |
| 2016-09-30 | $5.1M | 191k | 26.61 |
| 2016-06-30 | $4.1M | 188k | 22.05 |